¹⁷⁷Lu-Vipivotide Tetraxetan (¹⁷⁷Lu-PSMA-617, Pluvicto) Therapy

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

You are going to email the following 177Lu-Vipivotide Tetraxetan (177Lu-PSMA-617, Pluvicto) Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine Technology

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.